downgrades to NEUTRAL @45.51. Stock more appropriately valued now
initiates with a BUY @3.750. Very high Price/book, and potential for growth. Plus a down day for biotech companies provides an opportunity to get in.
initiates with a BUY @19.87. Buy while prices are still low, new development projects will boost the price as production increases.